Xerostomia induced by radiotherapy: An overview of the physiopathology, clinical evidence, and management of the oral damage

Therapeutics and Clinical Risk Management

Volumn 11, Issue , 2015, Pages 171-188

  Pinna, Roberto ^a   Campus, Guglielmo ^b   Cumbo, Enzo ^c   Mura, Ida ^a   Milia, Egle ^b  

^a Department of Biomedical Science ^*  (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Management strategies; Radiation induced xerostomia; Salivary gland hypofunction

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT;

ADVERSE OUTCOME; ATTITUDE TO HEALTH; BONE NECROSIS; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; DIET THERAPY; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MOLECULAR PATHOLOGY; MOUTH FLORA; MOUTH HYGIENE; ORAL MUCOSITIS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT SAFETY; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; REVIEW; SALIVARY GLAND DISEASE; SALIVATION; SYSTEMATIC REVIEW; TURNOVER TIME; XEROSTOMIA;

EID: 84922355968     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S70652     Document Type: Review

References (70)

1. Bivona PL. Xerostomia. A common problem among the elderly. N Y State Dent J. 1998;64:46-52
2. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003;20:64-77
3. Waltimo T, Christen S, Meurman JH, Filippi A. Dental care of patients with leukemia. Schweiz Monatsschr Zahnmed. 2005;115: 308-315
4. Brand HS, Bots CP, Raber-Durlacher E. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J. 2009;207:E17
5. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72:841-846
6. Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dent J. 2011;56:290-295
7. Villa A, Polimeni A, Strohmenger L, Cicciù D, Gherlone E, Abati S. Dental patients’ self-reports of xerostomia and associated risk factors. J Am Dent Assoc. 2011;142:811-816
8. Busato IM, Ignácio SA, Brancher JA, Grégio AM, Machado MA, Azevedo-Alanis LR. Impact of xerostomia on the quality of life of adolescents with type 1 diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:376-382
9. Moore P, Guggenheimer J, Etzel JK, Weyant RJ. Trevor orchard type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:281-291
10. Jensen SB, Pedersen AM, Vissink A, et al; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18: 1039-1060
11. Fox PC, Bunch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987;115:581-584
12. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:28-46
13. De Graeff A, De Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol. 1999;35:27-32
14. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695-1709
15. Globocan.iarc.fr [homepage on the Internet]. Lyon; International Agency for Research on Cancer; World Health Organization; 2012 [updated January 9, 2014]. Available from: http://globocan.iarc.fr/Default.aspx. Accessed May 1, 2014
16. Maciejewski B, Zajusz A, Pilecki B, et al; Salivary Gland Hypofunction/ Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother Oncol. 1991;22:7-11
17. Scully C, Epstein JB. Oral health care for the cancer patient. Eur J Cancer B Oral Oncol. 1996;32:281-292
18. Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J. 2000;50:140-161
19. Vissink A, Kalicharan D, S-Gravenmade EJ, et al. Acute irradiation effects on morphology and function of rat submandibular glands. J Oral Pathol Med. 1991;20:449-456
20. Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual flow during high dose radiotherapy. Radiother Oncol. 2001;61:271-274
21. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck. 2001;23:389-398
22. Franzén L, Funegård U, Ericson T, Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. Eur J Cancer. 1992;28:457-462
23. Dreizen SA, Daly TE, Drane JB, Brown LR. Oral complications of cancer radiotherapy. Postgrad Med. 1977;61:85-92
24. Ben-Aryeh H, Gutman D, Szargel R, Laufer D. Effects of irradiation on saliva in cancer patients. Int J Oral Surg. 1975;14:205-210
25. Dreizen S, Brown LR, Handler S, Levy BM. Radiation-induced xerostomia in cancer patients. Effect on salivary and serum electrolytes. Cancer. 1976;38:273-278
26. Marks JE, Davis CC, Gottsman VL, Purdy JE, Lee F. The effects of radiation of parotid salivary function. Int J Radiat Oncol Biol Phys. 1981;7:1013-1019
27. Ben-Aryeh H, Miron D, Berdicevsky I, Szargel R, Gutman D. Xerostomia in the elderly: prevalence, diagnosis, complications and treatment. Gerodontology. 1985;4:77-82
28. Abelson DC, Mandel ID. The effect of saliva on plaque pH in vivo. J Dent Res. 1981;60:1634-1638
29. Lingström P, Birkhed D. Plaque pH and oral retention after consumption of starchy snack products at normal and low salivary secretion rate. Acta Odontol Scand. 1993;51:379-388
30. Eliasson L, Birkhed D, Osterberg T, Carlén A. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. Eur J Oral Sci. 2006;114:494-499
31. Almståhl A, Wikström M. Oral microflora in subjects with reduced salivary secretion. J Dent Res. 1998;78:1410-1416
32. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer. 1993;71:1848-1851
33. Makkonen TA, Tenovuo J, Vilja P, Heimdahl A. Changes in the protein composition of whole saliva during radiotherapy in patients with oral or pharyngeal cancer. Oral Surg Oral Med Oral Pathol. 1986;62:270-275
34. Izutsu KT, Truelove EL, Bleyer WA, Anderson WM, Schubert MM, Rice JC. Whole saliva albumin as an indicator of stomatitis in cancer therapy patients. Cancer. 1981;48(6):1450-1454
35. Brown LR, Dreizen S, Handler S, Johnston DA. Effect of radiation induced xerostomia on human oral microflora. J Dent Res. 1974; 54(4):740-750
36. Keene HJ, Daly T, Brown LR, et al. Dental caries and Streptococcus mutans prevalence in cancer patients with irradiation-induced xerostomia: 1-13 years after radiotherapy. Caries Res. 1981;15: 416-427
37. Hase JC, Birkhed D. Salivary glucose clearance, dry mouth and pH changes in dental plaque in man. Arch Oral Biol. 1988;33: 875-880
38. Ravald N, List T. Caries and periodontal conditions in patients with primary Sjögren’s syndrome. Swed Dent J. 1998;22(3):97-103
39. Almståhl A, Wikström M, Groenink J. Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins. Oral Microbiol Immunol. 2001;16:345-352
40. Almståhl A, Carlén A, Eliasson L, Lingström P. Lactobacillus species in supragingival plaque in subjects with hyposalivation. Arch Oral Biol. 2010;55:255-259
41. Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health Syst Pharm. 2013;70:1025-1032
42. Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck. 2002;24:737-747
43. Sher DJ, Balboni TA, Haddad RI, et al. Efficacy and toxicity of chemo-radiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck. Int J Radiat Oncol Biol Phys. 2011;80: 1405-1411
44. Schoenfeld JD, Sher DJ, Norris CM Jr, et al. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or with-out concurrent chemotherapy. Int J Radiat Oncol Biol Phys. 2012; 82:308-314
45. Atkinson JC, Wu AJ. Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc. 1994;125:409-416
46. Spielman AI. Gustducin and its role in taste. J Dent Res. 1998; 77:539-544
47. Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis. 2002;8:117-129
48. Ramirez-Amador V, Silverman S Jr, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:149-153
49. Chen TY, Webster JH. Oral monilia study on patients with head and neck cancer during radiotherapy. Cancer. 1974;34:246-249
50. Samaranayake LP, Lamey PJ. Oral candidosis: 1. Clinicopathological aspects. Dent Update. 1988;15(6):227-228; 230-231
51. Kuntz R, Allen M, Osburn J. Xerostomia. Int J Pharm Compd. 2000; 4:1176-1177
52. Almeida JP, Kowalski LP. Pilocarpine used to treat xerostomia in patients submitted to radioactive iodine therapy: a pilot study. Braz J Otorhinolaryngol. 2010;76(5):659-662
53. Koseki M, Maki Y, Matsukubo T, Ohashi Y, Tsubota K. Salivary flow and its relationship to oral signs and symptoms in patients with dry eyes. Oral Dis. 2004;10(2):75-80
54. Tomiita M, Takei S, Kuwada N, et al. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren’s syndrome. Mod Rheumatol. 2010;20(5):486-490
55. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452-460
56. Hendrickson RG, Morocco AP, Greenberg MI. Pilocarpine toxicity and the treatment of xerostomia. J Emerg Med. 2004;26(4):429-432
57. Chambers MS, Jones CU, Biel MA, et al. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007;69(5):1369-1376
58. Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68(4):1102-1109
59. Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with the bile secretion-stimulant drug anethole trithione: a clinical trial. Am J Med Sci. 1999;318:146-151
60. Bagheri H, Schmitt L, Berlan M, Montastruc JL. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs. Eur J Clin Pharmacol. 1997;52:339-342
61. Dyke S. Clinical management and review of Sjögren’s syndrome. Int J Pharm Compd. 2000;4:338-341
62. Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC. Acupuncture for pilocarpine-resistant xerostomia following radio-therapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2001;50:353-357
63. Sagar SM. Acupuncture as an evidence-based option for symptom control in cancer patients. Curr Treat Options Oncol. 2008;9:117-126
64. Jedel E. Acupuncture in xerostomia a systematic review. J Oral Rehabil. 2005;32:392-396
65. Jensen SB, Pedersen AM, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010;18(8):1061-1079
66. O’Sullivan EM, Higginson IJ. Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review. Acupunct Med. 2010;28:191-199
67. Zhuang L, Yang Z, Zeng X, et al. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review. Integr Cancer Ther. 2013;12: 197-205
68. Diaz-Arnold AM, Marek CA. The impact of saliva on patient care: a literature review. J Prosthet Dent. 2002;88:337-343
69. Momm F, Volegova-Neher NJ, Schulte-Monting J, Guttenberger R. Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol. 2005;181:231-236
70. Davies A. Clinically proved treatments for xerostomia were ignored. BMJ. 1998;316:1247